Accessibility Menu
 
Bausch + Lomb logo

Bausch + Lomb

(NYSE) BLCO

Current Price$16.58
Market Cap$5.63B
Since IPO (2022)-21%
5 YearN/A
1 Year+18%
1 Month-9%

Bausch + Lomb Financials at a Glance

Market Cap

$5.63B

Revenue (TTM)

$5.10B

Net Income (TTM)

$360.00M

EPS (TTM)

$-1.02

P/E Ratio

-15.61

Dividend

$0.00

Beta (Volatility)

0.74 (Low)

Price

$16.58

Volume

753,666

Open

$16.07

Previous Close

$16.68

Daily Range

$15.89 - $16.76

52-Week Range

$10.45 - $18.91

BLCO: Motley Fool Moneyball Superscore

63

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bausch + Lomb

Industry

Healthcare Equipment and Supplies

Employees

13,000

CEO

Brenton L. Saunders, MBA

Headquarters

Vaughan, ON L4K 4B4, CA

BLCO Financials

Key Financial Metrics (TTM)

Gross Margin

59%

Operating Margin

3%

Net Income Margin

-7%

Return on Equity

-6%

Return on Capital

1%

Return on Assets

-3%

Earnings Yield

-6.41%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.63B

Shares Outstanding

354.32M

Volume

753.67K

Short Interest

0.00%

Avg. Volume

418.05K

Financials (TTM)

Gross Profit

$3.00B

Operating Income

$159.00M

EBITDA

$572.00M

Operating Cash Flow

$283.00M

Capital Expenditure

$349.00M

Free Cash Flow

$66.00M

Cash & ST Invst.

$383.00M

Total Debt

$5.37B

Bausch + Lomb Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$1.41B

+9.8%

Gross Profit

$816.00M

+4.7%

Gross Margin

58.08%

N/A

Market Cap

$5.63B

N/A

Market Cap/Employee

$417.31K

N/A

Employees

13,500

N/A

Net Income

$58.00M

-1833.3%

EBITDA

$257.00M

+32.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$4.99B

-7.7%

Accounts Receivable

$1.22B

+19.0%

Inventory

$976.00M

-5.8%

Long Term Debt

$5.29B

+8.8%

Short Term Debt

$77.00M

+6.9%

Return on Assets

-2.57%

N/A

Return on Invested Capital

1.31%

N/A

Free Cash Flow

$61.80M

+188.3%

Operating Cash Flow

$134.34M

+510.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PTCTPTC Therapeutics, Inc.
$68.75+0.91%
TGTXTG Therapeutics, Inc.
$33.58+1.08%
TFXTeleflex Incorporated
$118.42-0.99%
GKOSGlaukos Corporation
$112.64+4.63%

Trending Stocks

Symbol / CompanyPricePrice Chg
CYCNCyclerion Therapeutics
$6.38+3.12%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.23+0.04%
NKENike
$44.63-0.16%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.45-0.01%

Questions About BLCO

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.